RSS

Brexit

Rich Quelch, global head of marketing, Origin, looks at how Brexit will affect regulatory bodies in the UK and how this impacts pharmaceutical packagers. Read more

Opinion

Here, editor Reece Armstrong catches up with some of pharma’s leading names to see what else is in store for 2019. Read more

Analysis

Mark Street-Docherty, CEO of Elucigene Diagnostics, explains why the UK’s Industrial Strategy is the shining light amongst the shambles of Brexit. Read more

Opinion

Reece Armstrong examines the looming possibility of a 'no deal' Brexit and why the industry is entering the golden age of innovation. Read more

Opinion

The government is being asked to provide clarity on whether it can guarantee access to medicines and medical products in the event of a ‘no deal’ Brexit. Read more

News

Smaller companies are expected to drive innovation across Europe, according to the latest report from Pharmapack. Read more

News

An extension to Article 50 would benefit pharmaceutical manufacturers trading with Europe, according to an industry logistics expert. Read more

News

This week (16 January) saw prime minister Theresa May’s Brexit deal firmly defeated in the House of Commons bringing forward the very real possibility of a ‘no deal’ Brexit. Read more

News

Disruption for pharmaceutical manufacturers could be intensified by delays in introducing the UK’s new system for managing customs declarations, a logistics expert has said. Read more

News

As part of its ‘no deal’ Brexit plans, the Department of Health (DoH) has signed two contracts to store drugs in warehouses, queries by The Guardian have revealed. Read more

News

EPM editor Reece Armstrong examines the impact a no-deal Brexit would place on medicines supply in the UK. Read more

Opinion

Brexit, the upcoming medical device regulation (MDR) and IVDR were among the topics discussed at the MedPharmPlast Europe (MPPE) conference in Brussels. Read more

News

With the end result of Brexit fast approaching, labelling supplier Kallik looks at the implications Brexit could place on labelling and compliance in the pharmaceutical sector. Read more

Opinion

Pharmaceutical companies must make additional plans to prepare for a ‘no deal’ Brexit, health secretary Matt Hancock has said. Read more

News 1 Comments

A “Norway Plus” Brexit will be the least damaging to the pharmaceutical manufacturing sector, according to an industry logistics expert. Read more

News

Concerns have been raised over the government’s contingency plans for whether the UK can ensure a suitable supply of medicines in the event of a ‘no deal’ Brexit. Read more

News

Brexit negotiators have a duty to protect millions of patients on both sides of the Channel, a coalition from the UK’s health sector has said. Read more

News

The Association of the British Pharmaceutical Industry (ABPI) has responded to the Withdrawal Agreement, marking it as an "important step" towards securing a Brexit deal. Read more

News

The chief executive of the Association of the British Pharmaceutical Industry (ABPI) will tell the House of Commons DExEU Select Committee how they are preparing for a ‘No Deal’ Brexit. Read more

News

In her last Editor's Desk feature, Felicity Thomas analyses how Brexit is going to affect the pharma industry and what we can expect from the EMA and MHRA. Read more

News